DARU Journal of Pharmaceutical Sciences has published its
inaugural articles with BioMed Central. Amongst these are an editorial by Editor-in-Chief Mohammad Abdollahi
which highlights the need for a quality, open-access journal in the field of
pharmaceutical sciences. The launch
articles also include original research on enhancing indomethacin release in vitro, and propylene glycol tolerance
in neonates, as well as a review article on the status of lead pollution and
toxicity in Iran.
The word ‘DARU’ is derived from
the Persian name for drug and the journal aims to act as a platform for all
areas of drug conception, design, manufacture, classification and
assessment. The journal is published on
behalf of the Tehran University of Medical Sciences, who also cover the article
processing charges in the journal.